Solicitation of Nominations for Membership To Serve on the National Advisory Council on Migrant Health, 27790-27791 [2019-12592]

Download as PDF jbell on DSK3GLQ082PROD with NOTICES 27790 Federal Register / Vol. 84, No. 115 / Friday, June 14, 2019 / Notices available at https://www.fda.gov/ AdvisoryCommittees/Calendar/ default.htm. Scroll down to the appropriate advisory committee meeting link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before July 2, 2019. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by July 3, 2019. Persons attending FDA’s advisory committee meetings are advised that FDA is not responsible for providing access to electrical outlets. For press inquiries, please contact the Office of Media Affairs at fdaoma@ fda.hhs.gov or 301–796–4540. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact Yinghua Wang (see FOR FURTHER INFORMATION CONTACT) at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our website at https://www.fda.gov/ AdvisoryCommittees/AboutAdvisory Committees/ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: June 10, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. SUPPLEMENTARY INFORMATION: [FR Doc. 2019–12559 Filed 6–13–19; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 17:04 Jun 13, 2019 Jkt 247001 Health Resources and Services Administration Solicitation of Nominations for Membership To Serve on the National Advisory Council on Migrant Health Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Request for nominations. AGENCY: HRSA is seeking nominations of qualified candidates to be considered for appointment as members of the National Advisory Council on Migrant Health (NACMH/Council). The NACMH consults with and makes recommendations to the HHS Secretary concerning the organization, operation, selection, and funding of migrant health centers (MHC) and other entities, under grants and contracts under the Public Health Service (PHS) Act. HRSA is seeking nominations to fill up to five positions on the NACMH with individuals served by nominating health centers. DATES: HRSA will receive written nominations for NACMH membership on a continuous basis. ADDRESSES: Nomination packages must be submitted in hardcopy to the Designated Federal Official (DFO), NACMH, Strategic Initiatives and Planning Division, Office of Policy and Program Development, Bureau of Primary Health Care, HRSA, 16N38B, 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: All requests for information regarding NACMH nominations should be sent to Esther Paul, DFO, NACMH, HRSA, in one of three ways: (1) Send a request to the following address: Esther Paul, Strategic Initiatives and Planning Division, Office of Policy and Program Development, Bureau of Primary Health Care, HRSA, 16N38B, 5600 Fishers Lane, Rockville, Maryland 20857; (2) call 301–594–4300; or (3) send an email to epaul@hrsa.gov. A copy of the NACMH charter and list of the current membership are available on the NACMH website at https:// bphc.hrsa.gov/qualityimprovement/ strategicpartnerships/nacmh/ index.html. SUMMARY: NACMH was established and authorized under section 217 of the PHS Act, as amended (42 U.S.C. 218), to consult with and make recommendations to the HHS Secretary concerning the organization, PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 operation, selection, and funding of MHCs, and other entities under grants and contracts under section 330 of the PHS Act (42 U.S.C. 254b). The NACMH meets twice each calendar year, or at the discretion of the DFO in consultation with the NACMH Chair. Authority: NACMH is authorized under section 217 of the PHS Act, as amended (42 U.S.C. 218), and established by the Secretary. The NACMH is governed by the Federal Advisory Committee Act (5 U.S.C. Appendix 2) (FACA), which sets forth standards for the formation and use of advisory committees. Nominations: HRSA requests nominations for voting members to serve as Special Government Employees (SGEs) on the NACMH. The nominations are to fill five open positions with MHC governing board members who are served by the nominating MHC and who are familiar with the delivery of health care to migratory and seasonal agricultural workers. The Secretary appoints NACMH members with the expertise needed to fulfill the duties of the Advisory Committee. The membership requirements set forth in section 217 of the PHS Act, as amended (42 U.S.C. 218), require that the Council consist of 15 members, at least 12 of whom shall be members of the governing boards of MHCs or other entities assisted under section 330 of the PHS Act (42 U.S.C. 254b). Of such 12 members, at least 9 shall be chosen from among those members served by such health centers and familiar with the delivery of health care to migratory and seasonal agricultural workers. The remaining three Council members shall be individuals qualified by training and experience in the medical sciences or in the administration of health programs. New members filling a vacancy that occurred prior to the expiration of a term may serve only for the remainder of such term. Members may serve after the expiration of their terms until their successors have taken office, but no longer than 120 days. Nominees must reside in the United States, and international travel cannot be funded. Individuals selected for appointment to NACMH will be invited to serve for up to 4 years as SGEs. Members appointed as SGEs receive a stipend and reimbursement for per diem and travel expenses incurred for attending NACMH meetings, as authorized by 5 U.S.C. 5703 of the FACA for persons employed intermittently in government service. A complete nomination package should include the following information for each nominee: (1) A E:\FR\FM\14JNN1.SGM 14JNN1 Federal Register / Vol. 84, No. 115 / Friday, June 14, 2019 / Notices NACMH nomination form; (2) three letters of reference; (3) a statement of prior service on the NACMH; and (4) a biographical sketch of the nominee or a copy of his/her curriculum vitae. Nomination packages may be submitted directly by the nominated individual or by the person/organization recommending the candidate. HHS will endeavor to ensure NACMH membership is fairly balanced, representing points of view and individuals of diverse geographic areas, gender, and ethnic and minority groups, as well as individuals with disabilities. Appointments shall be made without discrimination based on age, ethnicity, gender, sexual orientation, or cultural, religious, or socioeconomic status. Individuals selected to be considered for appointment will be required to provide detailed information regarding their financial holdings, consultancies, and research grants or contracts. Disclosure of this information is required in order for HRSA ethics officials to determine whether there are conflicts between the SGE’s public duties as a member of the NACMH and their private interests, including an appearance of a loss of impartiality as defined by federal laws and regulations, and to identify any required remedial action needed to address the potential conflict(s). Maria G. Button, Director, Division of the Executive Secretariat. [FR Doc. 2019–12592 Filed 6–13–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jbell on DSK3GLQ082PROD with NOTICES National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; System VerDate Sep<11>2014 17:04 Jun 13, 2019 Jkt 247001 for the Spec. of Acute THC Imp. Using (1220). Date: June 20, 2019. Time: 10:00 a.m. to 11:00 a.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, 301–827– 5817, mcguireso@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Preparation and Distribution of Research Drug Products (8952). Date: June 25, 2019. Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892– 9550, (301) 827–5702, lf33c.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Clinical Research Coordination Center (2249). Date: July 16, 2019. Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892– 9550, (301) 827–5702, lf33c.nih.gov. (Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: June 10, 2019. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–12525 Filed 6–13–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 27791 amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders. Date: July 15, 2019. Time: 8:30 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Brian Hoshaw, Ph.D., Scientific Review Officer, National Eye Institute, National Institutes of Health, Division of Extramural Research, 6700 B Rockledge Dr., Ste 3400, Rockville, MD 20892, 301–451–2020, hoshawb@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: June 10, 2019. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–12526 Filed 6–13–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 84, Number 115 (Friday, June 14, 2019)]
[Notices]
[Pages 27790-27791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12592]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Solicitation of Nominations for Membership To Serve on the 
National Advisory Council on Migrant Health

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Request for nominations.

-----------------------------------------------------------------------

SUMMARY: HRSA is seeking nominations of qualified candidates to be 
considered for appointment as members of the National Advisory Council 
on Migrant Health (NACMH/Council). The NACMH consults with and makes 
recommendations to the HHS Secretary concerning the organization, 
operation, selection, and funding of migrant health centers (MHC) and 
other entities, under grants and contracts under the Public Health 
Service (PHS) Act. HRSA is seeking nominations to fill up to five 
positions on the NACMH with individuals served by nominating health 
centers.

DATES: HRSA will receive written nominations for NACMH membership on a 
continuous basis.

ADDRESSES: Nomination packages must be submitted in hardcopy to the 
Designated Federal Official (DFO), NACMH, Strategic Initiatives and 
Planning Division, Office of Policy and Program Development, Bureau of 
Primary Health Care, HRSA, 16N38B, 5600 Fishers Lane, Rockville, 
Maryland 20857.

FOR FURTHER INFORMATION CONTACT: All requests for information regarding 
NACMH nominations should be sent to Esther Paul, DFO, NACMH, HRSA, in 
one of three ways: (1) Send a request to the following address: Esther 
Paul, Strategic Initiatives and Planning Division, Office of Policy and 
Program Development, Bureau of Primary Health Care, HRSA, 16N38B, 5600 
Fishers Lane, Rockville, Maryland 20857; (2) call 301-594-4300; or (3) 
send an email to [email protected]. A copy of the NACMH charter and list 
of the current membership are available on the NACMH website at https://bphc.hrsa.gov/qualityimprovement/strategicpartnerships/nacmh/index.html.

SUPPLEMENTARY INFORMATION: NACMH was established and authorized under 
section 217 of the PHS Act, as amended (42 U.S.C. 218), to consult with 
and make recommendations to the HHS Secretary concerning the 
organization, operation, selection, and funding of MHCs, and other 
entities under grants and contracts under section 330 of the PHS Act 
(42 U.S.C. 254b). The NACMH meets twice each calendar year, or at the 
discretion of the DFO in consultation with the NACMH Chair.
    Authority: NACMH is authorized under section 217 of the PHS Act, as 
amended (42 U.S.C. 218), and established by the Secretary. The NACMH is 
governed by the Federal Advisory Committee Act (5 U.S.C. Appendix 2) 
(FACA), which sets forth standards for the formation and use of 
advisory committees.
    Nominations: HRSA requests nominations for voting members to serve 
as Special Government Employees (SGEs) on the NACMH. The nominations 
are to fill five open positions with MHC governing board members who 
are served by the nominating MHC and who are familiar with the delivery 
of health care to migratory and seasonal agricultural workers. The 
Secretary appoints NACMH members with the expertise needed to fulfill 
the duties of the Advisory Committee. The membership requirements set 
forth in section 217 of the PHS Act, as amended (42 U.S.C. 218), 
require that the Council consist of 15 members, at least 12 of whom 
shall be members of the governing boards of MHCs or other entities 
assisted under section 330 of the PHS Act (42 U.S.C. 254b). Of such 12 
members, at least 9 shall be chosen from among those members served by 
such health centers and familiar with the delivery of health care to 
migratory and seasonal agricultural workers. The remaining three 
Council members shall be individuals qualified by training and 
experience in the medical sciences or in the administration of health 
programs. New members filling a vacancy that occurred prior to the 
expiration of a term may serve only for the remainder of such term. 
Members may serve after the expiration of their terms until their 
successors have taken office, but no longer than 120 days. Nominees 
must reside in the United States, and international travel cannot be 
funded.
    Individuals selected for appointment to NACMH will be invited to 
serve for up to 4 years as SGEs. Members appointed as SGEs receive a 
stipend and reimbursement for per diem and travel expenses incurred for 
attending NACMH meetings, as authorized by 5 U.S.C. 5703 of the FACA 
for persons employed intermittently in government service.
    A complete nomination package should include the following 
information for each nominee: (1) A

[[Page 27791]]

NACMH nomination form; (2) three letters of reference; (3) a statement 
of prior service on the NACMH; and (4) a biographical sketch of the 
nominee or a copy of his/her curriculum vitae. Nomination packages may 
be submitted directly by the nominated individual or by the person/
organization recommending the candidate.
    HHS will endeavor to ensure NACMH membership is fairly balanced, 
representing points of view and individuals of diverse geographic 
areas, gender, and ethnic and minority groups, as well as individuals 
with disabilities. Appointments shall be made without discrimination 
based on age, ethnicity, gender, sexual orientation, or cultural, 
religious, or socioeconomic status.
    Individuals selected to be considered for appointment will be 
required to provide detailed information regarding their financial 
holdings, consultancies, and research grants or contracts. Disclosure 
of this information is required in order for HRSA ethics officials to 
determine whether there are conflicts between the SGE's public duties 
as a member of the NACMH and their private interests, including an 
appearance of a loss of impartiality as defined by federal laws and 
regulations, and to identify any required remedial action needed to 
address the potential conflict(s).

Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-12592 Filed 6-13-19; 8:45 am]
BILLING CODE 4165-15-P